Return to Trial Database

NHL01-27

Phase I/II Study of CHOP plus Ontak, an Interleukin-2 Fusion Toxin for Patients with Peripheral T-cell Non-Hodgkin’s Lymphomas

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial NHL01-27 being conducted in.

No data was found